Thoracic outlet syndrome is a group of disorders that affect the upper extremity and neck, resulting in compression of the neurovascular bundle that exits the thoracic outlet. Depending on the type of compressed structure, the arterial, venous, and neurogenic forms of TOS are distinguished. In some populations, e.g., in certain groups of athletes, some sources report incidence rates as high as about 80 cases per 1000 people, while in the general population, it is equal to 2–4 per 1000. Although the pathogenesis of this condition appears relatively simple, there are a very large number of overlapping risk factors that drive such a high incidence in certain risk groups. Undoubtedly, a thorough knowledge of them and their etiology is essential to estimate the risk of TOS or make a quick and accurate diagnosis.

The diagnostic process that allows pronator syndrome to be differentiated reliably from carpal tunnel syndrome remains a challenge for clinicians, as evidenced by the most common cause of pronator syndrome misdiagnosis: carpal tunnel syndrome. Pronator syndrome can be caused by compression of the median nerve as it passes through the anatomical structures of the forearm, while carpal tunnel syndrome refers to one particular topographic area within which compression occurs, the carpal tunnel. The present narrative review is a complex clinical comparison of the two syndromes with their anatomical backgrounds involving topographical relationships, morphology, clinical picture, differential diagnosis, and therapeutic options. It discusses the most frequently used diagnostic techniques and their correct interpretations. Its main goal is to provide an up-to-date picture of the current understanding of the disease processes and their etiologies, to establish an appropriate diagnosis, and introduce relevant treatment benefiting the patient.

Background: Total hip arthroplasty (THA) is a well-established and effective treatment for advanced osteoarthritis (OA) of the hip joint. While commonly performed in older patients, THA is increasingly used in younger individuals, especially in cases of secondary coxarthrosis. Technological advances have led to the development of specialized implants, which allow surgeons to address severe post-inflammatory or dysplastic deformities. Younger patients undergoing THA, often in their 20s or 30s, present higher functional expectations. Despite limited long-term studies, research indicates a higher rate of revision surgeries in this age group compared to older populations, making these procedures a unique challenge. Methods: This retrospective study analyzed 5263 primary total hip arthroplasties (THAs) performed at our center between May 1985 and December 2016. After excluding cemented and hybrid implants, as well as patients lost to follow-up or with other etiologies, 101 uncemented THA procedures in 92 patients aged 30 years or younger were included. The majority (64.4%) were due to dysplastic coxarthrosis (DDH), while avascular necrosis (26.7%) and juvenile rheumatoid arthritis (8.9%) accounted for the rest. The average patient age was 25.6 years, with a mean follow-up period of over 24 years. Surgical technique involved the anterolateral approach, with implants placed in the true acetabular region. Implants included Munich/Plasmacup, Mittelmeier, and P-M designs. Implant survival was estimated using the Kaplan–Meier estimator to determine the probability of implant longevity over the follow-up period. Outcomes were assessed using Merle d’Aubigné and Postel scores, modified by Charnley, alongside radiographic evaluations based on the Crowe, De Lee, and Gruen classifications. Results: Preoperatively radiological assessment of all hips was classified as grade IV according to the Kellgren–Lawrence scale. Over an average follow-up of 24 years, final outcomes using the modified Merle d’Aubigné and Postel (MAP) classification were excellent in 24%, good in 37%, satisfactory in 8%, and poor in 32% of cases. Results compared between DDH group and control group indicate significantly more poor results for the DDH group compared to the control group (p-value < 0.05). All poor outcomes were associated with prosthesis loosening, primarily involving P-M and Mittelmeier acetabular components. Complications included intraoperative fractures in five cases, peripheral nerve dysfunction in six cases, and heterotopic ossification in eight cases. Postoperative pain scores on the VAS scale improved from 6.8 to 1.7. The Kaplan–Meier estimator indicated 10-year survival rates of 85.2% for the entire prosthesis, with 69.8% survival at 15 years and 54.5% at 20 years. For each period the bio-functionality according to Kaplan–Meier estimator was in favor of the control group. Conclusions: Cementless THA in patients aged 30 or younger has demonstrated itself to be an efficacious treatment for hip osteoarthritis, yielding favorable bio-functional outcomes in both short- and long-term follow-up. Nevertheless, THA performed in the context of developmental dysplasia of the hip (DDH) carries a significantly elevated risk of postoperative complications, most notably aseptic loosening, which critically undermines implant survival rates. Given the young demographic and the anticipated prolonged functional lifespan of the prosthesis, there is an increased propensity for loosening over time, necessitating vigilant and sustained postoperative surveillance.

The aim of the study was to analyze results of hip arthroplasty with the use of the hydroxy-apatite-coated Corail stem. The study group consisted of 134 patients (85 females and 49 males) who underwent 138 hip joint arthroplasties with the use of the Corail stem. The mean age of the patients at surgery was 56.8 years (range from 22 to 75 years). The mean follow-up period was 110.45 months. Before surgery all patients were calssified as poor according to the Merle d'Aubigne i Postela classification modified by Charnley. The mean post-operative improvement was 6.8 points. The outcomes were classified as excellent in 98 patients, good in 26, satisfactory in 8 and poor in 6. Poor results were always related to loosening of implant components: aseptic loosening of the acetabular cup in 4 cases, of the stem in 1 case and septic loosening of the whole endoprothesis in 1 case. Periosteal calcification was noted in 13 cases (9.4%). According to the Kaplan-Meier estimator, 8 years' survival rate was 93.33% for the whole implant and 97.77% for the stem. 1. Our follow-up data from a mean of nearly 10 years indicate that the use of the Corail stem substantially reduces hip pain and produces a lasting good clinical outcome. 2. With good surgical technique and in the absence of complications, the risk of aseptic loosening is minimal.

The aim of this paper is to present the results of hip joint arthroplasty with the use of the Taperloc stem. The study group consisted of 117 patients (75 women and 42 men) who underwent 121 hip joint arthroplasties with Taperloc stems. Mean age of the patients at surgery was 53.8 years (range: 2475 years). Mean follow-up period was 159.5 months. Pre-operative Merle d'Aubigne-Postel scores (modified by Charnley) of the study group were poor in all patients. Mean post-operative improvement was 6.6 points. Excellent results were obtained in 86 cases, good in 19, fair in 9 and poor in 7 cases. Poor results were always associated with implant component loosening: 5 cases of acetabular cup loosening, 1 case of a loosened stem and 1 septic loosening of the entire endoprosthesis. In six cases (4.9%), patients developed heterotopic ossification. According to the Kaplan-Meier estimator, 10 years' survival probability was 94.21% for the whole endoprosthesis and 98.34% for the stem alone. 1. Our follow-up data covering a mean period of over 13 years showed that the use of the Ta-perloc stem substantially reduces hip pain and results in a good lasting clinical outcome. 2. With good surgical technique and in the absence of complications, the risk of aseptic loosening is minimal.

Background: Hip joint pain due to arthritis is a prevalent issue in adults, often necessitating surgical intervention such as total hip arthroplasty (THA). This procedure has been celebrated for its reliability; however, successful outcomes depend on numerous factors. Current advancements are focused on improving implant design and surgical methodologies. This study aimed to evaluate the long-term clinical and functional outcomes of uncemented total hip arthroplasty utilizing the L-Cup acetabular component. Methods: Between February 1999 and November 2010, 351 L-Cup components were implanted in 315 patients. A follow-up period ranged from 14 to 25 years. The clinical outcomes were assessed using the modified Merle d’Aubigné and Postel (MAP) classification and patient satisfaction was measured using a Visual Analog Scale (VAS). Results: Postoperative evaluations showed significant improvement, with VAS scores decreasing from a mean of 7.2 to 2.1, indicating substantial pain alleviation. The modified MAP classification showed a significant improvement of 6.3 points throughout the follow-up period. The results revealed that 49.5% of the cases were classified as excellent, while 20.5% had poor outcomes due to prosthesis loosening. According to the Kaplan–Meier estimator, the 5-year survival rate for the acetabular component was 97.78%, with survival rates of 90.5% at 10 years, 80.45% at 15 years, and 73.79% at 20 years. Conclusions: Total hip arthroplasty is an effective treatment for advanced degenerative joint diseases. While significant postoperative improvements were documented, the observed prosthesis loosening in 20.5% of cases raises concerns about the long-term effectiveness of the L-Cup acetabular component and suggests the need for further refinement in surgical techniques and implant design.